Aspiriant LLC’s Capital One COF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
5,766
+1,043
+22% +$200K 0.03% 161
2026
Q1
$862K Sell
4,723
-234
-5% -$48.9K 0.02% 165
2025
Q4
$1.2M Buy
4,957
+844
+21% +$188K 0.03% 149
2025
Q3
$874K Buy
4,113
+335
+9% +$73.3K 0.03% 156
2025
Q2
$804K Buy
3,778
+867
+30% +$162K 0.03% 163
2025
Q1
$522K Buy
2,911
+67
+2% +$12.7K 0.02% 188
2024
Q4
$507K Buy
2,844
+201
+8% +$34.8K 0.02% 187
2024
Q3
$396K Sell
2,643
-266
-9% -$37.9K 0.02% 205
2024
Q2
$403K Sell
2,909
-311
-10% -$43.6K 0.02% 199
2024
Q1
$479K Buy
3,220
+146
+5% +$19.8K 0.02% 204
2023
Q4
$403K Buy
3,074
+158
+5% +$17K 0.02% 209
2023
Q3
$283K Buy
2,916
+216
+8% +$23.1K 0.01% 232
2023
Q2
$295K Sell
2,700
-3
-0.1% -$300 0.01% 226
2023
Q1
$260K Hold
2,703
0.01% 233
2022
Q4
$251K Buy
2,703
+217
+9% +$21.3K 0.01% 235
2022
Q3
$229K Buy
2,486
+7
+0.3% +$745 0.01% 238
2022
Q2
$259K Sell
2,479
-212
-8% -$25.9K 0.01% 228
2022
Q1
$354K Sell
2,691
-60
-2% -$8.75K 0.02% 207
2021
Q4
$398K Buy
2,751
+330
+14% +$51K 0.02% 197
2021
Q3
$392K Sell
2,421
-165
-6% -$26.9K 0.02% 174
2021
Q2
$401K Buy
2,586
+120
+5% +$18.1K 0.02% 176
2021
Q1
$314K Buy
2,466
+84
+4% +$9.9K 0.02% 176
2020
Q4
$236K Buy
+2,382
New +$203K 0.02% 190
2020
Q3
Sell
-3,581
Closed -$225K 217
2020
Q2
$225K Sell
3,581
-434
-11% -$27K 0.02% 170
2020
Q1
$203K Buy
4,015
+33
+0.8% +$2.9K 0.02% 178
2019
Q4
$410K Hold
3,982
0.04% 152
2019
Q3
$363K Sell
3,982
-300
-7% -$27K 0.03% 166
2019
Q2
$389K Sell
4,282
-899
-17% -$80.4K 0.03% 166
2019
Q1
$424K Sell
5,181
-200
-4% -$16.3K 0.03% 152
2018
Q4
$407K Buy
5,381
+500
+10% +$43.3K 0.03% 155
2018
Q3
$463K Sell
4,881
-12
-0.2% -$1.17K 0.04% 161
2018
Q2
$450K Sell
4,893
-752
-13% -$71.2K 0.04% 169
2018
Q1
$541K Buy
+5,645
New +$562K 0.05% 149
2017
Q3
Sell
-2,479
Closed -$205K 206
2017
Q2
$205K Buy
+2,479
New +$201K 0.02% 198

Other funds holding COF

Aspiriant LLC's COF Position: Q2 2026 in Review

Aspiriant LLC increased its Capital One (COF) stake by 22% in Q2 2026, buying an estimated $200K and bringing the position to 5,766 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #161.

Aspiriant LLC first reported a position in COF in Q2 2017 and has held it in 34 quarters since. The position peaked at $1.2M in Q4 2025. 413 funds tracked by Wall St. Rank hold COF as of Q2 2026.

  • Aspiriant LLC held 5,766 shares of Capital One worth $1.16M as of Q2 2026.
  • Aspiriant LLC bought 1,043 Capital One shares in Q2 2026, an estimated $200K.
  • Capital One made up 0.03% of Aspiriant LLC's portfolio in Q2 2026, its #161 holding.
  • Aspiriant LLC first reported a position in Capital One in Q2 2017 and has held it in 34 quarters since.
  • Aspiriant LLC's Capital One position peaked at $1.2M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Capital One as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.